Accolade Inc
NASDAQ:ACCD
Accolade Inc
Accrued Liabilities
Accolade Inc
Accrued Liabilities Peer Comparison
Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Accolade Inc
NASDAQ:ACCD
|
Accrued Liabilities
$50.9m
|
CAGR 3-Years
19%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Accrued Liabilities
$1B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
5%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Accrued Liabilities
$153m
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
CVS Health Corp
NYSE:CVS
|
Accrued Liabilities
$24.1B
|
CAGR 3-Years
15%
|
CAGR 5-Years
15%
|
CAGR 10-Years
17%
|
|
Cigna Corp
NYSE:CI
|
Accrued Liabilities
$8.9B
|
CAGR 3-Years
2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Accrued Liabilities
$820.6m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
9%
|
See Also
What is Accolade Inc's Accrued Liabilities?
Accrued Liabilities
50.9m
USD
Based on the financial report for Feb 28, 2023, Accolade Inc's Accrued Liabilities amounts to 50.9m USD.
What is Accolade Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
21%
Over the last year, the Accrued Liabilities growth was 7%. The average annual Accrued Liabilities growth rates for Accolade Inc have been 19% over the past three years , 21% over the past five years .